Fundz

Who to call at Azenta, and when

Fundz watches for the moments Azenta starts buying, and tells you who to reach.

  • An alert the day Azenta raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Azenta, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Azenta. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Azenta Enters into Elegen Agreements for Exclusive License and Supply of Gene Synthesis Products

Oct 30, 2026

Contract Type

licensing

BurlingtonBiotechnologyHealth CareLife Science

Description

On October 28, 2026, Azenta, Inc. signed a Technology, Equipment and License Agreement and a Master Services and Supply Agreement with Elegen Corp. These agreements empower Azenta to utilize Elegen's proprietary technology for gene synthesis while also securing essential consumables and services. The initial term of the license is five years, with potential for conversion to an irrevocable license after 12 to 18 months

Company Information

Company

Azenta

Location

Burlington, Massachusetts, United States

About

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey and B Medical Systems. Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com. INVESTOR CONTACTS:Sara SilvermanHead of Investor Relations & Corporate Communicationsir@azenta.com Sherry Dinsmoresherry.dinsmore@azenta.com

Predictive Intelligence
Strategic

ML-powered predictions for Azenta's next move

Learn about Strategic plan

Azenta signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.